Cited by 63Sleep and related disordersSleep and Wakefulness ResearchCircadian rhythm and melatonin

Neuroscience-driven discovery and development of sleep therapeutics

Dresler, M., Spoormaker, V.I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., Holsboer, F.·2014·Pharmacology & Therapeutics

Abstract

Until recently, neuroscience has given sleep research and discovery of better treatments of sleep disturbances little attention, despite the fact that disturbed sleep has overwhelming impact on human health. Sleep is a complex phenomenon in which specific psychological, electrophysiological, neurochemical, endocrinological, immunological and genetic factors are involved. The brain as both the generator and main object of sleep is obviously of particular interest, which makes a neuroscience-driven view the most promising approach to evaluate clinical implications and applications of sleep research. Polysomnography as the gold standard of sleep research, complemented by brain imaging, neuroendocrine testing, genomics and other laboratory measures can help to create composite biomarkers that allow maximizing the effects of individualized therapies while minimizing adverse effects. Here we review the current state of the neuroscience of sleep, sleep disorders and sleep therapeutics and will give some leads to promote the discovery and development of sleep medicines that are better than those we have today.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.10.012

Cites

691 of 691 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Objective PSG and actigraphy show indicators of disrupted sleep in RA patients compared with healthy controls, including increases in α-EEG intrusion, arousals, sleep stage shifts, sleep fragmentation, and nocturnal wake time.

    “Based on objective PSG and actigraphy assessment, various indicators of disrupted sleep have been reported in RA patients compared with healthy control participants, including increases in α-EEG intrusion, arousals, sleep stage shifts, sleep fragmentation, and nocturnal wake time (54, 160, 237, 351, 472).”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [160]

Cites

Flagged first, then by citations

6 of the 697 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F.
Affiliations
  • Max Planck Institute of Psychiatry (DE)
  • Max Planck Society (DE)
Corresponding author
Holsboer, F.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2014-03
Volume
141
Issue
3
Pages
300-334
ISSN
0163-7258 (ISSN-L)
OpenAlex
W2065074889
Cited by
63
References
697
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 5 · 2013: 1 · 2012: 1
FWCI
1.27
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Digital Library (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
sleep disorders, polysomnography, neuroimaging, composite biomarker, personalized treatment, adverse effects
MeSH terms
Animals, Brain, Humans, Neurosciences, Sleep, Sleep Wake Disorders, Drug Design, Polysomnography, Biomedical Research, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review